Results 61 to 70 of about 191,607 (163)

Correction: The cost of community outreach HIV interventions: a case study in Thailand. [PDF]

BMC Public Health
Soe KM, Hauck K, Jiamton S, Kongsin S.
europepmc   +1 more source

Predictive modeling of corporate financial risk and its implications for health economics and public health efficiency. [PDF]

Front Public Health
Zhi W, Kang Y.
europepmc   +1 more source

Présentation : Walras et l’intervention publique

Œconomia, 2011
Jean-Pierre Potier
doaj  

Retraction Note: Study on the spatial and temporal evolution characteristics and spatial influencing factors of carbon emission intensity in commercial land. [PDF]

Sci Rep
Tian N, Tan L.
europepmc   +1 more source

Free Riding in Healthcare Through a Game-Theoretic Lens: A Cross-Domain Narrative Review and Conceptual Synthesis. [PDF]

Healthcare (Basel)
Ntais C, Talias MA.
europepmc   +1 more source

Correction: Economic costs of veterinary drug and antibiotic use in commercial dairy cattle herds in Central European countries. [PDF]

Front Vet Sci
Ózsvári L, Dobos A, Máté M.
europepmc   +1 more source

Moving beyond moral indignation: global health governance in an era of defunding. [PDF]

Eur J Public Health
Bekker M.
europepmc   +1 more source

Metaverses in economics and public administration (ecosystem aspect)

Муниципалитет: экономика и управление
Introduction. The article examines the concept of metaverses (MV) as a new universal form of socio-economic relations in the context of the transition to industry-society 5.0.
Igor P. Chelak
doaj  

The private solution trap in collective action problems across 34 nations. [PDF]

Proc Natl Acad Sci U S A
Malthouse E, Pilgrim C, Sgroi D, Accerenzi M, Alfonso A, Ashraf RU, Baard M, Banerjee S, Belianin A, Bhattacharjee S, Bhattacharya M, Brañas-Garza P, Cárdenas JC, Carriquiry M, Choi S, Clochard GJ, Denzon EE, Dessoulavy-Sliwinski B, Dini G, Dong L, Ertl A, Exadaktylos F, Filiz-Ozbay E, Flecke SL, Galeotti F, Garcia-Muñoz T, Hanaki N, Hollard G, Horn D, Huang L, İriş D, Kiss HJ, Koch J, Kovářík J, Kwarteng OKB, Lange A, Leites M, Leung TH, Lim W, Morren M, Nockur L, Okyere CY, Oudah M, Ozkes AI, Page L, Park J, Pfattheicher S, Proestakis A, Ramos C, Ramos-Sosa M, Ashraf MS, Sanjaya MR, Schwaiger R, Sene O, Song F, Spycher S, Staněk R, Tanchingco N, Tavoni A, Te Velde V, Vázquez-De Francisco MJ, Visser M, Wang JT, Wang W, Weng WC, Werner K, Wijayanti A, Winkler R, Wooders J, Ying L, Zhen W, Hills T.   +71 more
europepmc   +1 more source

Correction: Budget impact analysis of the introduction of ranibizumab's biosimilar to the Jordanian joint procurement system. [PDF]

Front Public Health
Hamida JA, Alkhatib NS, Hammour KA, Halloush S, Kurdi A, Balkhi B, Alfayez OM, Mousa R.   +7 more
europepmc   +1 more source